Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.Res. 242

ResolutionFederalHouseIn Committee
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
About This Bill
Committee
Latest Action · March 19, 2019
Referred to the Subcommittee on Health.
Congress
116th (2019–2021)
Introduced
March 18, 2019
Cosponsors (6)
4D 2R
View PDF ↗

Summary

Highlight any text to annotate
This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.